Cargando…

NMDA Receptor Antagonists Increase the Release of GLP-1 From Gut Endocrine Cells

Type 2 diabetes mellitus (T2DM) remains one of the most pressing health issues facing modern society. Several antidiabetic drugs are currently in clinical use to treat hyperglycaemia, but there is a need for new treatments that effectively restore pancreatic islet function in patients. Recent studie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cyranka, Malgorzata, Monfeuga, Thomas, Vedovato, Natascia, Larabee, Chelsea M, Chandran, Anandhakumar, Toledo, Enrique M, de Wet, Heidi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9091448/ https://www.ncbi.nlm.nih.gov/pubmed/35571112 http://dx.doi.org/10.3389/fphar.2022.861311

Ejemplares similares

N‐terminal alterations turn the gut hormone GLP‐2 into an antagonist with gradual loss of GLP‐2 receptor selectivity towards more GLP‐1 receptor interaction
por: Gabe, Maria Buur Nordskov, et al.
Publicado: (2022)

NMDA Receptor Antagonists for Treatment of Depression
por: Ates-Alagoz, Zeynep, et al.
Publicado: (2013)

Abcc5 Knockout Mice Have Lower Fat Mass and Increased Levels of Circulating GLP‐1
por: Cyranka, Malgorzata, et al.
Publicado: (2019)

A Ketone Ester Drink Lowers Human Ghrelin and Appetite
por: Stubbs, Brianna J., et al.
Publicado: (2017)

Allosteric antagonist action at triheteromeric NMDA receptors
por: Gibb, Alasdair J.
Publicado: (2022)

NMDA receptor antagonists ketamine and Ro25-6981 inhibit evoked release of glutamate in vivo in the subiculum
por: Stan, T L, et al.
Publicado: (2014)

Modulation of Functional EEG Networks by the NMDA Antagonist Nitrous Oxide
por: Kuhlmann, Levin, et al.
Publicado: (2013)

NMDA antagonists for treating the non-motor symptoms in Parkinson’s disease
por: Vanle, Brigitte, et al.
Publicado: (2018)

Is Memantine Effective as an NMDA Receptor Antagonist in Adjunctive Therapy for Schizophrenia?
por: Kikuchi, Tetsuro
Publicado: (2020)

Promises and Pitfalls of NMDA Receptor Antagonists in Treating Violent Aggression
por: Bartsch, Caitlyn J., et al.
Publicado: (2022)

Novel agonist and antagonist radioligands for the GLP‐2 receptor. Useful tools for studies of basic GLP‐2 receptor pharmacology
por: Gadgaard, Sarina, et al.
Publicado: (2022)

Functional module detection through integration of single-cell RNA sequencing data with protein–protein interaction networks
por: Klimm, Florian, et al.
Publicado: (2020)

Behavioral Consequences of NMDA Antagonist-Induced Neuroapoptosis in the Infant Mouse Brain
por: Yuede, Carla M., et al.
Publicado: (2010)

NMDA Receptor Antagonist Ketamine Impairs Feature Integration in Visual Perception
por: Meuwese, Julia D. I., et al.
Publicado: (2013)

Effects of Memantine, an NMDA Antagonist, on Metabolic Syndromes in Female NMRI Mice
por: Osanloo, Naser, et al.
Publicado: (2015)

NMDA Receptor Antagonist Attenuates Bleomycin-Induced Acute Lung Injury
por: Li, Yang, et al.
Publicado: (2015)

Safety and effectiveness of NMDA receptor antagonists for depression: A multidisciplinary review
por: Moore, Thomas J., et al.
Publicado: (2022)

MLX plays a key role in lipid and glucose metabolism in humans: Evidence from in vitro and in vivo studies
por: Nagarajan, Shilpa R., et al.
Publicado: (2023)

GLP-1 and GLP-2 Orchestrate Intestine Integrity, Gut Microbiota, and Immune System Crosstalk
por: Abdalqadir, Nyan, et al.
Publicado: (2022)

Normal gut microbiome in NMDA receptor encephalitis
por: Herken, Julia, et al.
Publicado: (2019)

The two C-terminal tyrosines stabilize occluded Na/K pump conformations containing Na or K ions
por: Vedovato, Natascia, et al.
Publicado: (2010)

Route, mechanism, and implications of proton import during Na(+)/K(+) exchange by native Na(+)/K(+)-ATPase pumps
por: Vedovato, Natascia, et al.
Publicado: (2014)

Glucagon-Like Peptide-1 (GLP-1) in the Integration of Neural and Endocrine Responses to Stress
por: Diz-Chaves, Yolanda, et al.
Publicado: (2020)

NMDA receptor modulation of glutamate release in activated neutrophils
por: del Arroyo, Ana Gutierrez, et al.
Publicado: (2019)

Synthesis of benzopolycyclic cage amines: NMDA receptor antagonist, trypanocidal and antiviral activities
por: Torres, Eva, et al.
Publicado: (2012)

The effects of NMDA receptor antagonists on attentional set-shifting task performance in mice
por: Kos, Tomasz, et al.
Publicado: (2010)

Inhibition of Acetylcholinesterase Modulates NMDA Receptor Antagonist Mediated Alterations in the Developing Brain
por: Bendix, Ivo, et al.
Publicado: (2014)

Early Use of the NMDA Receptor Antagonist Ketamine in Refractory and Superrefractory Status Epilepticus
por: Zeiler, F. A.
Publicado: (2015)

GLP-2 cures the gut – What about the liver?
por: Pakarinen, Mikko P.
Publicado: (2019)

Metabolic and gut microbiome changes following GLP-1 or dual GLP-1/GLP-2 receptor agonist treatment in diet-induced obese mice
por: Madsen, Mette Simone Aae, et al.
Publicado: (2019)

Glucose in the hypothalamic paraventricular nucleus regulates GLP-1 release
por: Ma, Yue, et al.
Publicado: (2020)

What combines best with GLP-1 for obesity treatment: GIP receptor agonists or antagonists?
por: Holst, Jens Juul
Publicado: (2021)

Increased Body Weight and Fat Mass After Subchronic GIP Receptor Antagonist, but Not GLP-2 Receptor Antagonist, Administration in Rats
por: Baldassano, Sara, et al.
Publicado: (2019)

Ephenidine: A new psychoactive agent with ketamine-like NMDA receptor antagonist properties
por: Kang, Heather, et al.
Publicado: (2017)

NMDA receptor antagonists attenuate intrathecal morphine-induced pruritus through ERK phosphorylation
por: Shen, Le, et al.
Publicado: (2018)

Enantiopure Indolo[2,3-a]quinolizidines: Synthesis and Evaluation as NMDA Receptor Antagonists
por: Pereira, Nuno A. L., et al.
Publicado: (2016)

The effect of memantine, an antagonist of the NMDA glutamate receptor, in in vitro and in vivo infections by Trypanosoma cruzi
por: Santos Souza, Higo Fernando, et al.
Publicado: (2019)

The Computer Simulation of Therapy with the NMDA Antagonist in Excitotoxic Neurodegeneration in an Alzheimer’s Disease-like Pathology
por: Świetlik, Dariusz, et al.
Publicado: (2022)

Glutamate NMDA Receptor Antagonists with Relevance to Schizophrenia: A Review of Zebrafish Behavioral Studies
por: Benvenutti, Radharani, et al.
Publicado: (2022)

Glucagon receptor antagonist upregulates circulating GLP-1 level by promoting intestinal L-cell proliferation and GLP-1 production in type 2 diabetes
por: Lang, Shan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u2plnu3cfkn67qdgl6me9v5b3v